M

MannKind Corp
D

MNKD

6.17000
USD
0.14
(2.24%)
Market Closed
Volume
81,771
EPS
0
Div Yield
-
P/E
77
Market Cap
1,701,548,366
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -3.460
    (-2.00%)
    169.130 USD
    A
    ACAD
    -0.085
    (-0.48%)
    17.805 USD
    A
    ACRS
    0.00000
    (0.00%)
    2.58500 USD
    A
    ADAP
    -0.00560
    (-0.97%)
    0.57280 USD
    A
    AGIO
    0.790
    (2.37%)
    34.060 USD
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    A
    AMRN
    -0.00020
    (-0.04%)
    0.54890 USD
    A
    ASMB
    0.282
    (1.97%)
    14.610 USD
    A
    ATNM
    0.01000
    (0.75%)
    1.34000 USD
    B
    BHC
    0.24500
    (3.28%)
    7.72500 USD
    BMY
    BMY
    0.025
    (0.04%)
    57.075 USD
    C
    CARA
    -0.07000
    (-1.49%)
    4.63000 USD
    C
    CGEN
    0.14000
    (6.22%)
    2.39000 USD
    C
    CRBP
    -0.620
    (-5.18%)
    11.350 USD
    C
    CRIS
    -0.16000
    (-4.68%)
    3.26000 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    D
    DVAX
    -0.255
    (-2.01%)
    12.430 USD
    E
    EXEL
    -3.560
    (-9.77%)
    32.880 USD
    F
    FATE
    0.03000
    (2.28%)
    1.34500 USD
    F
    FGEN
    -0.02950
    (-5.49%)
    0.50740 USD
    F
    FOLD
    0.03500
    (0.37%)
    9.54500 USD
    G
    GERN
    0.03500
    (1.18%)
    2.99500 USD
    G
    GLPG
    0.075
    (0.31%)
    23.920 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    I
    IOVA
    0.11000
    (1.87%)
    5.98500 USD
    I
    ITCI
    0.730
    (0.58%)
    127.240 USD
    K
    KALA
    -0.07000
    (-0.91%)
    7.61000 USD
    K
    KPTI
    -0.01090
    (-1.60%)
    0.67170 USD
    N
    NKTR
    0.02170
    (2.39%)
    0.93110 USD
    N
    NVCR
    -0.110
    (-0.41%)
    26.830 USD
    O
    OMER
    0.13500
    (1.47%)
    9.29500 USD
    O
    ORMP
    0.00000
    (0.00%)
    2.31000 USD
    PFE
    PFE
    -0.621
    (-2.33%)
    26.015 USD
    P
    PRTA
    0.260
    (1.84%)
    14.370 USD
    Q
    QURE
    0.390
    (2.61%)
    15.310 USD
    R
    RIGL
    0.030
    (0.14%)
    21.830 USD
    S
    SRRK
    1.840
    (4.10%)
    46.700 USD
    T
    TBPH
    0.21000
    (2.30%)
    9.36000 USD
    T
    TGTX
    -0.690
    (-2.31%)
    29.150 USD
    V
    VERU
    -0.03500
    (-3.24%)
    1.04500 USD
    V
    VSTM
    0.12500
    (2.32%)
    5.51000 USD
    X
    XNCR
    0.250
    (1.22%)
    20.690 USD
    More
News

Title: MannKind Corp

Sector: Healthcare
Industry: Biotechnology
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.